Incyte Stock Price (NASDAQ:INCY)

Add to My Stocks
$134.02 $2.81 (2.14%) INCY stock closing price Feb 27, 2017 (Closing)
YOUR DAILY UPDATE ON
INCY
Incyte
27 FEB 2017
amigobulls logo
INCY hand_up
INCY vs S&P 500
Closing Price: Feb 27, 2017
INCY
$134.02 ( 2.14%)
S&P 500
2369.8 ( 0.1%)
INCY
52 Week Price Range
1 Year Return: 78.52%
Q4 Growth*
Excellent
Profitable ?
Yes
net image
2016 Q4 Net Profit
9.4%
PE Valuation
Expensive*
home image
Rating
INCY EXCELLENT
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Incyte Snapshot Video

12 5 2

INCY Stock Details

Prev Close* : $131.21
Market Cap:
$24.85B
Day Low: $130.24
52 Week Low: $60.30
Open: $131.88
Volume: 33192954
Day High: $134.97
52 Week High: $134.97
Dividend:
N/A

Incyte Stock Articles & Video

more news on INCY stock

Incyte News - From Partners

Picking Up Where We Left Off   by Zacks on Feb 22, 2017
Banks Loved Yellen's Testimony   by Zacks on Feb 15, 2017

INCY Stockcharts

View INCY PE ratio, PS ratio stocks charts and compare with peers.
INCY Chart
Note: Compare Incyte stock price history with the index and industry peers.

Incyte Valuation

PE ratio
(price earnings ratio)
248.19
PS ratio (
price to sales ratio
)
22.86
PB ratio (
price to book ratio
)
85.08

Incyte Returns

ROE
(return on equity)
65%

Incyte Financial Ratios

Asset Turnover
0.73
Receivables Turnover
9.08
Debt to Equity
1.74

INCY Industry Peers

Company Price Change (%)
Alexion Pharma (ALXN)132.20.66 (0.5%)
Illumina (ILMN)166.826.82 (4.26%)
Pfizer (PFE)34.280.02 (0.06%)
Eli Lilly (LLY)83.060.19 (0.23%)
Novartis (NVS)77.580.3 (0.39%)
Geron (GERN)2.20.05 (2.33%)
Merck (MRK)65.850.31 (0.47%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)1.630.25 (18.12%)
Epizyme (EPZM)13.651.5 (12.35%)
OncoMed Pharma (OMED)10.251.12 (12.27%)
Peregrine Pharma (PPHM)0.5710.06 (11.67%)
Alnylam Pharma (ALNY)51.314.69 (10.06%)
Acorda Therapeutics (ACOR)27.42.5 (10.04%)
Ultragenyx Pharma (RARE)85.167.69 (9.93%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 28, 2017
CompanyPriceChange (%)
Horizon Pharma (HZNP)16.480.97 (5.56%)
Kamada (KMDA)6.9840.21 (2.92%)
Anika Therapeutics (ANIK)48.491.26 (2.53%)
VIVUS (VVUS)1.120.02 (1.75%)
PDL BioPharma (PDLI)2.190.03 (1.35%)
Idera Pharma (IDRA)1.650.02 (1.2%)
China Biologic Products (CBPO)107.881.22 (1.12%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 28, 2017

Incyte Financial Statements

income statement20152014201320122011
Net Sales Or Revenues753.75M511.49M354.94M297.05M94.45M
Net Income6.53M-48.48M-83.14M-44.32M-186.54M
Total Operating Expense676.12M513.29M370.41M295.75M237.63M
view Incyte Corporation income statement
balance sheet20152014201320122011
Total Assets1.01B830.06M629.56M330.41M328.96M
Total Liabilities836.28M911.69M822.67M505.37M556.03M
Shareholders Equity171.15M-81.62M-193.1M-174.95M-227.07M
view Incyte Corporation balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-34.84M-29.11M-4.48M-118.43M-31.24M
Net Cash From (Used By) Operating Activities86.53M26.25M9.18M-94.83M-161.71M
Increase (Decrease) In Prop Plant And Equipment-26M-27.87M-4.26M-2.83M-3.79M
view Incyte Corporation cashflow statement

Incyte Corporation Stock News - Partner Headlines

Incyte Stock Message Board

Incyte stock price ended the last trading day at 134.02. Stock price or share price can be used to find the total market value of a company. Incyte market cap stands at 24.85B as of 27 Feb, 2017. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Incyte stock analysis.

For recognizing and analyzing the real performance of Incyte stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 33192954 INCY shares were traded yesterday, and Incyte stock chart shows that the INCY stock quote hit a day high of 134.97 and day low of 130.24. Incyte stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.